Financial News
Travere Therapeutics Inc (NQ: TVTX )
8.980
+0.410
(+4.78%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
All News about Travere Therapeutics Inc
![](/next-assets/images/schema-image-default.png)
Earnings Preview For Travere Therapeutics
February 14, 2024
Via Benzinga
![](https://ml.globenewswire.com/media/e7252f5a-bd9e-4e33-9eb0-153976c06a3f/small/travere-txtm-inline-fullcolor-png.png)
![](https://ml.globenewswire.com/media/e7252f5a-bd9e-4e33-9eb0-153976c06a3f/small/travere-txtm-inline-fullcolor-png.png)
![](https://ml.globenewswire.com/media/e7252f5a-bd9e-4e33-9eb0-153976c06a3f/small/travere-txtm-inline-fullcolor-png.png)
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2.jpeg?width=1200&height=800&fit=crop)
Where Travere Therapeutics Stands With Analysts
December 15, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/e7252f5a-bd9e-4e33-9eb0-153976c06a3f/small/travere-txtm-inline-fullcolor-png.png)
Travere Therapeutics Provides Corporate Update and 2024 Outlook
January 08, 2024
Via GlobeNewswire
![](https://ml.globenewswire.com/media/e7252f5a-bd9e-4e33-9eb0-153976c06a3f/small/travere-txtm-inline-fullcolor-png.png)
![](https://cdn.benzinga.com/files/images/story/2023/12/21/calt.png?width=1200&height=800&fit=crop)
Calliditas Therapeutics Scores Complete FDA Approval, Broader Label For Lead Kidney Disease Drug
December 21, 2023
Via Benzinga
Exposures
Product Safety
![](https://ml.globenewswire.com/media/e7252f5a-bd9e-4e33-9eb0-153976c06a3f/small/travere-txtm-inline-fullcolor-png.png)
![](https://cdn.benzinga.com/files/images/story/2023/12/05/ai-generated-8210911_1280.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/12/06/thor_industries_-_logo_0.jpg?width=1200&height=800&fit=crop)
THOR Industries Reports Upbeat Earnings, Joins Dave & Buster's Entertainment, Campbell Soup And Other Big Stocks Moving Higher On Wednesday
December 06, 2023
Via Benzinga
Topics
Stocks
Exposures
US Equities
![](https://cdn.benzinga.com/files/images/story/2023/12/05/image44.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/12/05/daktronics_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
Where Travere Therapeutics Stands With Analysts
November 20, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Tuesday's Intraday Session
December 05, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/12/05/nio_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Monday's After-Market Session
December 04, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/e7252f5a-bd9e-4e33-9eb0-153976c06a3f/small/travere-txtm-inline-fullcolor-png.png)
![](/next-assets/images/schema-image-default.png)
Preview: Travere Therapeutics's Earnings
November 06, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/e7252f5a-bd9e-4e33-9eb0-153976c06a3f/small/travere-txtm-inline-fullcolor-png.png)
![](https://ml.globenewswire.com/media/e7252f5a-bd9e-4e33-9eb0-153976c06a3f/small/travere-txtm-inline-fullcolor-png.png)
Travere Therapeutics Reports Third Quarter 2023 Financial Results
November 07, 2023
Via GlobeNewswire
![](https://ml.globenewswire.com/media/e7252f5a-bd9e-4e33-9eb0-153976c06a3f/small/travere-txtm-inline-fullcolor-png.png)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/e7252f5a-bd9e-4e33-9eb0-153976c06a3f/small/travere-txtm-inline-fullcolor-png.png)
Travere Therapeutics to Report Third Quarter 2023 Financial Results
October 24, 2023
Via GlobeNewswire
![](https://ml.globenewswire.com/media/e7252f5a-bd9e-4e33-9eb0-153976c06a3f/small/travere-txtm-inline-fullcolor-png.png)
![](https://ml.globenewswire.com/media/e7252f5a-bd9e-4e33-9eb0-153976c06a3f/small/travere-txtm-inline-fullcolor-png.png)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.